What it is: A 16-amino-acid peptide encoded in mitochondrial DNA that acts as a retrograde signaling molecule, traveling from mitochondria to regulate systemic metabolism.
Research suggests: Preclinical studies show it improves insulin sensitivity, activates AMPK pathways, reduces age-related metabolic decline, and extends lifespan in some models.
Best for: Longevity and metabolic health researchers
Key thing to know: One of the only peptides encoded in mitochondrial rather than nuclear DNA, representing a genuinely novel area of biology distinct from most peptide research.
What is MOTS-c?
MOTS-c (Mitochondrial ORF of the 12S rRNA type-c) is a 16-amino-acid peptide encoded within mitochondrial DNA — a rare signaling molecule originating from the mitochondrial genome, not the nuclear genome. Identified in 2015 at the University of Southern California, it acts as a retrograde, hormone-like molecule: made inside mitochondria, it travels to the nucleus and other tissues to regulate metabolism systemically.
The discovery of MOTS-c added a new category to biology, mitochondria-derived peptides (MDPs), and raised fundamental questions about how mitochondria communicate with the rest of the cell and body. Researchers study it primarily for metabolic regulation, insulin sensitivity improvement, exercise performance enhancement, age-related metabolic decline, and obesity-related metabolic dysfunction.
How it works.
In research, the proposed mechanism has several parts.
Metabolic sensor: MOTS-c acts as a metabolic stress sensor and regulator. When cells experience metabolic stress, such as during exercise, fasting, or nutrient deprivation, MOTS-c expression increases, and the peptide translocates from the mitochondria to the cell nucleus. There it activates AMPK (AMP-activated protein kinase), often described as the master metabolic switch.
AMPK activation: AMPK activation in turn promotes glucose uptake into muscle cells, fat oxidation, and mitochondrial biogenesis, increasing the number and efficiency of mitochondria over time.
In plain terms: Think of MOTS-c as a signal from the mitochondria that says “we need more energy efficiency,” triggering a cellular cascade that improves how cells use glucose and fat for fuel. Research also suggests exercise-mimetic properties — producing some metabolic adaptations of physical activity at the cellular level, including improved insulin-stimulated glucose disposal and reduced lipid accumulation in muscle.
Decline with age: Circulating MOTS-c levels have been shown to decline with age in human studies, paralleling the age-related decline in metabolic flexibility. This has made MOTS-c a subject of particular interest in the longevity and healthy aging research community, as exogenous supplementation may partially restore a signaling environment more similar to younger metabolic states.
What the research shows.
The research evidence breaks down as follows.
Preclinical data: Preclinical studies in rodent models have produced some of the most compelling metabolic findings in the MOTS-c literature. In diet-induced obese mice, administration reversed insulin resistance and reduced fat accumulation without changes in caloric intake. In aged mice, it restored exercise capacity toward levels seen in younger animals, drawing interest from longevity researchers.
Human research: Human research is at an earlier stage but emerging. Studies have confirmed that circulating MOTS-c levels decline with aging and in conditions of metabolic dysfunction, supporting its physiological relevance. Initial human data supports AMPK pathway activation and improved metabolic parameters in early-stage investigations.
Evidence level: The evidence tier is Moderate, robust and compelling preclinical data across independent research groups, with early but promising human research that has not yet produced large-scale RCT data.
Biomarkers to review first.
Research protocols referencing MOTS-c most commonly consider metabolic baseline markers. Testing these before exploring this peptide gives you and your healthcare provider the most relevant starting context.
See the full lab testing guide →What it's commonly researched with.
In research contexts, MOTS-c has been studied alongside compounds that share overlapping metabolic and longevity pathways, particularly NAD+ and AMPK activation targets. The combinations below represent what appears in the research literature, not recommendations for use.